Please login to the form below
Opioid epidemic
This page shows the latest Opioid epidemic news and features for those working in and with pharma, biotech and healthcare.
Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined
Throughout the legal proceedings related to the opioid-related allegations, neither Teva nor AbbVie admitted to any wrongdoing. ... The finalised agreements with Allergan and Teva are significant steps forward in our continued efforts to hold those
Latest news
-
Teva reaches proposed $4.25bn agreement to settle US opioid lawsuits
Teva will also need to settle an ongoing dispute with Allergan over opioid liability, having acquired Allergan’s generic drugs business in 2016. ... subdivisions, to resolve the majority of our costly legacy opioids litigation and, importantly, make
-
US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan
the opioid epidemic. ... chronic pain, unexpectedly became part of an opioid crisis that has brought grief and loss to far too many families and communities.”.
-
US President Biden nominates Robert Califf as FDA commissioner
who said that she looked forward to working with him “to see our nation through this pandemic and to tackle other critical challenges like the ongoing opioid crisis, rising youth tobacco ... Manchin also said that “correcting the culture” at the
-
Purdue to pay over $8bn to settle opioid-related criminal claims
Purdue Pharma has reached an $8m+ settlement with the US Department of Justice to avoid federal civil and criminal charges related to claims it helped fuel the country’s opioid epidemic. ... The new company will provide opioid overdose reversal
-
Mallinckrodt files for bankruptcy protection in the US
in fuelling the opioid epidemic. ... Another opioid drugmaker – Purdue Pharma – filed for bankruptcy last year following increasing blame for its part in driving the US opioid epidemic.
More from news
Approximately 15 fully matching, plus 19 partially matching documents found.
Latest Intelligence
-
20 for 2020 – Five pharma leaders to watch in 2020
Hahn is taking over as the FDA is being thrust into the spotlight on a number of issues, including how to deal with medicine prices, the opioid epidemic, hastening access to
-
20 for 2020 – Five pharma companies to watch
year. We’re talking about the lawsuits J&J is facing claiming damages as a result of using its products, including opioid painkillers, Baby Powder talc and its schizophrenia drug Risperdal ... epidemic in opioid abuse and overdose-related deaths in the
-
Trust: the ultimate elevator
This is particularly apparent for the traditional ‘big pharma’ sector – shaken by scandals such as pricing, manipulative patent litigation and a rampant opioid epidemic.
-
How digital content helps HCPs curb opioid abuse through better prescribing decisions
opioid abuse epidemic. ... The pain management topic found under most specialties at Univadis highlights curated synopses of the best literature dealing with the opioid abuse epidemic, including an overview of 12 predictors of patient
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
"Legal highs" ruling leaves illegal labs laughing
So we are acutely aware of the devastation caused by the opioid epidemic in the US, and the criticism aimed at Purdue, the maker of OxyContin. ... We have also pitched for agents designed to treat opioid overdose and alcohol abuse.
-
How digital content is helping physicians curb the opioid abuse epidemic
On the other hand are the prescribers who are driven to help their patients but finding that their pain management protocols are now complicated by what the national opioid abuse epidemic ... The pain management topic found under most specialties at
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- COVID-19 could be key in identifying viruses with pandemic potential
- Novo Nordisk Foundation commits €127m for new cell therapy facility
- Alzheimer’s Research UK launches ‘Change The Ending’ campaign
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
No results were found
PMHub
fox&cat
Fox&cat is an award-winning healthcare communications agency which creates inspirational campaigns and programmes that exceed expectations. Priding itself on delivering...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
